These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 880808)

  • 1. Evaluation of two dose schedules of 15 (S) 15 methyl PGF2alpha methyl ester vaginal suppositories for dilatation of cervix prior to vacuum aspiration for late first trimester abortions.
    Zoremthangi B; Agarwal N; Puri CP; Laumas KR; Saraya LK; Hingorani V
    Contraception; 1977 Mar; 15(3):285-93. PubMed ID: 880808
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative dilatation of the cervix by single vaginal administration of 15-methyl-PGF2alpha-methyl ester.
    Ganguli AC; Gréen K; Bygdeman M
    Prostaglandins; 1977 Oct; 14(4):779-84. PubMed ID: 339282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
    Karim SM; Choo HT; Cheng P
    Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 15(S) 15-methyl-PGF 2 alpha-methyl ester vaginal suppositories for cervical dilatation and second trimester pregnancy termination.
    Krishna UR; Mhatre V; Ganguli AC; Purandare VN
    Contraception; 1976 Dec; 14(6):661-70. PubMed ID: 1017200
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal administration of 15-methyl-PGF2 alpha-methyl ester prior to vacuum aspiration. Peri- and postoperative complications.
    Nilsson S; Johnell H; Langhoff-Roos J; Nyberg R; Gréen K
    Acta Obstet Gynecol Scand; 1983; 62(6):599-602. PubMed ID: 6670465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 15 (S) 15 methyl-PGF 2 alpha methyl ester suppositories with a two dose schedule for termination of early pregnancy.
    Zoremthangi B; Agarwal N; Puri CP; Laumas KR; Hingorani V
    Contraception; 1976 Nov; 14(5):519-27. PubMed ID: 975834
    [No Abstract]   [Full Text] [Related]  

  • 10. 15(S)15-methyl prostaglandin F2alpha for termination of very early human pregnancy. A comparative study of a single intramuscular injection and vaginal suppositories.
    Fylling P; Jerve F
    Prostaglandins; 1977 Oct; 14(4):785-90. PubMed ID: 339283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of prostaglandins by various routes for induction of abortion. Merits and demerits.
    Krishna U; Ganguli AC; Mandlekar AV; Purandare VN
    Prostaglandins; 1978 Apr; 15(4):685-93. PubMed ID: 674699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of the methyl ester of 15-methyl PGF2alpha in connection with intravenous and vaginal administration to the human.
    Gréen K; Bygdeman M
    Prostaglandins; 1976 May; 11(5):879-92. PubMed ID: 935517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of cervical resistance by prostaglandin suppositories prior to dilatation for induced abortion.
    Dingfelder JR; Brenner WE; Hendricks CH; Staurovsky LG
    Am J Obstet Gynecol; 1975 May; 122(1):25-30. PubMed ID: 1130444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative cervical dilatation with 15(S)15-methyl PGF2alpha methyl ester pessaries.
    Chatterjee TK; Grech ES; Niles L
    Int J Gynaecol Obstet; 1978; 15(5):423-7. PubMed ID: 28976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose vaginal 15 methyl prostaglandin F2 alpha for cervical dilatation prior to vacuum curettage abortion.
    Niloff JM; Stubblefield PG
    Am J Obstet Gynecol; 1982 Mar; 142(5):596-7. PubMed ID: 7036748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful first trimester abortion with 15(S) 15-methyl-prostaglandin F2alpha-methyl ester vaginal suppositories.
    Borell U; Bygdeman M; Leader A; Lundström V; Martin JN
    Contraception; 1976 Jan; 13(1):87-94. PubMed ID: 1245121
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of 15-methyl-prostaglandin F2 alpha used for dilating the cervix uteri before abortion on endogenous prostaglandin F2 alpha synthesis].
    Goncharova VN; Morozova MS; Razina LG; Manuilova IA; Murashko LE
    Akush Ginekol (Mosk); 1981 Dec; (12):37-8. PubMed ID: 6950671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic induction of abortion in the 1st and 2nd trimesters with intramuscular 15-methyl-prostaglandin F2 alpha].
    Göretzlehner G; Rudolf K; Frahm R
    Zentralbl Gynakol; 1977; 99(22):1356-60. PubMed ID: 602503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester.
    Bygdeman M; Martin JN; Leader A; Lundström V; Ramadan M; Eneroth P; Gréen K
    Obstet Gynecol; 1976 Aug; 48(2):221-4. PubMed ID: 940655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical dilation with prostaglandin F2 alpha for first trimester abortion.
    Natrajan PK; Tzingounis VA
    South Med J; 1986 Jul; 79(7):830-1. PubMed ID: 3460179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.